NEW YORK (GenomeWeb News) — PerkinElmer today said it plans to acquire privately held GPCR company Euroscreen Products for an undisclosed amount.
 
Euroscreen Products provides GPCR membranes, cell lines, and an aequorin-based cellular assay to drug makers.
 
PerkinElmer CEO Gregory Summe said the acquisition is the company’s “next step in our strategy to build the most comprehensive offering in cellular and drug discovery reagent technologies.”
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.